Page 207 - product-manual
P. 207

TM/MC  TM/MC
             PHARMACOLOGICAL ACTIVITIES - TOXICOLOGY - DRUG INTERACTIONS





                               Zinc (Citrate)

                               Zinc  plays  important  roles  in  growth  and  development,  the  immune  response,  neurological
                               function, and reproduction. On the cellular level, the function of zinc can be divided into three
                               categories:    catalytic,  structural,  and  regulatory  (Bowman  &  Russell,  2006).  Inadequate  zinc
                               supply, especially in growing animals, may lead to severe clinical signs within days, resulting in
                               growth depression, skin defects, impaired immune function, and growth disorders of the skeleton
                               (Ettinger  &  Feldman,  2000a).  Zinc  deficiency  in  the  dog  most  commonly  occurs  as  a  skin
                               condition called ‘zinc responsive dermatosis’ (Colombini, 1999; Campbell & Crow, 2010). The
                               usual symptoms are hair loss, and scaling and crusting of the skin around the face, head, and legs.
                               Lesions often encircle the mouth, chin, eyes, and ears. The foot pads may be scaly and the hair
                               coats are dull and dry.



                 Toxicity for zinc has not been documented in dogs and cats when administered orally in therapeutic doses.
                 However, zinc toxicosis caused by ingestion of foreign materials such as galvanized metal and pennies has been
            TOXICOLOGY  reported in dogs, but it has not been described in cats (Hardy et al., 2003). No evidence of significant pathological

                 effects were observed in rats following daily oral administration of zinc (as zinc citrate, zinc acetate, zinc oxide
                 or zinc maleate) in doses up to 34 mg/kg of body weight for 35 to 53 weeks. Oral LD  for zinc chloride is 350
                                                                                         50
                 mg/kg of body weight in rats and mice, 200-250 mg/kg of body weight in rabbits. Oral LD  for zinc sulphate is
                                                                                             50
                 2,200 mg/kg of body weight in rats and 2,100 mg/kg of body weight in rabbits (EMEA, 1996).




                   DRUG    Both quinolone antibiotics and tetracycline antibiotics interact with zinc in the gastrointestinal tract,
          INTERACTIONS     inhibiting the absorption of both zinc and the antibiotic (Lomaestro et al., 1995; Penttilä et al.,
                           1975). Zinc can reduce the absorption and action of penicillamine, a drug used to treat rheumatoid
                           arthritis (Brewer et al. 1993). Thiazide diuretics such as chlorthalidone and hydrochlorothiazide
                           increase urinary zinc excretion by as much as 60% (Wester, 1980).































        22 |   VimForte -VM TM
   202   203   204   205   206   207   208   209   210   211   212